ArticleJournal for immunotherapy of cancer2019

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.

Ulka Vaishampayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.